Sign up to save your podcasts
Or
Share The Implications of the Latest Data on SGLT2 Inhibitors in Heart Failure: A Unified Approach to Treatment?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Implications of the Latest Data on SGLT2 Inhibitors in Heart Failure: A Unified Approach to Treatment?
Drs Zieroth and Anker discuss heart failure (HF) outcome trials with sodium-glucose cotransporter-2 (SGLT2) inhibitors.
Credit available for this activity expires: 5/17/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/972924?src=mkm_podcast_addon_972924
View all episodes
By Medscape Podcasts
4
77 ratings
Drs Zieroth and Anker discuss heart failure (HF) outcome trials with sodium-glucose cotransporter-2 (SGLT2) inhibitors.
Credit available for this activity expires: 5/17/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/972924?src=mkm_podcast_addon_972924
More shows like Keeping Current
View all
NEJM This Week
320 Listeners
JAMA Clinical Reviews
497 Listeners
WSJ Tech News Briefing
1,639 Listeners
This Week in Cardiology
881 Listeners
The Bob Harrington Show
14 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
292 Listeners
The Curbsiders Internal Medicine Podcast
3,348 Listeners
The Peter Attia Drive
8,522 Listeners
Annals On Call Podcast
193 Listeners
JAMA Medical News
93 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
28 Listeners
Cardionerds: A Cardiology Podcast
425 Listeners
The Curious Clinicians
374 Listeners
Huberman Lab
29,188 Listeners
Not Otherwise Specified
65 Listeners